BIOLABO to launch new full automated coagulometer, SOLEA 100 at Arab Health 2016

- January 25th to 26th -

United Arab Emirates - January 2016: At the next Arab Health - MEDLAB exhibition from January 25 to 28, 2016, French firm BIOLABO will be introducing SOLEA 100, an analyzer for haemostasis capable of performing over 100 tests per hour. Featuring an exclusive 8-channel cuvette system, it is fast, reliable and cost-effective.

SOLEA 100 performs over 100 tests per hour in routine mode (PT + APTT + TT + FIB), thanks to optimal use of the cuvette racks. The very low dead volume (0.2 ml) saves considerably on reagent. Racks with unused cuvettes are returned for later use. The analyzer is made to the most exacting standards to ensure optimal reliability; all of the critical components are made in Europe, which means that it is particularly robust.

BIOLABO is a French firm that manufactures reagents and analyzers for medical biology, including almost 20 million coagulation tests per year. It has been in business for 36 years and offers three ranges of reagents: biochemistry (cholesterol, triglycerides, enzymes, etc.); coagulation (INR, partial thromboplastin time, fibrinogen, etc.); and specific proteins (HbA1c, CRP, etc.). It is therefore involved in the diagnosis of major pandemic diseases: cardiovascular disorders, diabetes, hepatitis, obesity, blood functions, etc.

The majority of BIOLABO's reagents have very long expiration dates — usually three years after manufacture — which gives distributors and users a comfortable competitive edge. Thanks to a sustained program of investments, the firm has 1 200 m² of laboratory space, 840 m3 of temperature-controlled storage space, and 2 000 m3 of ambient temperature storage space; it also uses a next-generation freeze dryer, which is able to handle up to 20 000 bottles of reagent.

The export market accounts for more than 95% of BIOLABO's production. One third goes to the Middle East, where it has a highly organized distribution network: there is an exclusive BIOLABO distributor in each country, employing engineers and technicians trained in France. Every year, BIOLABO takes part in twenty or so biology trade shows and congresses in the Near and Middle East. The Arabian Peninsula offers the greatest potential, as patients there are highly informed about medical technology. They are very demanding when it comes to the quality of medical testing, since around 70% of healthcare decisions are taken on the basis of diagnoses established through such tests. This requirement for quality produces a virtuous circle. It increases the vigilance of the public authorities and the professionalism of distributors, and drives continuous improvement among healthcare professionals.

Every year since 2004, BIOLABO has exhibited its products at the French Pavilion in the MEDLAB section. The size of its stand and the large number of visitors it receives reflects the strength of its reputation there. Moreover, visitors are advised to make an appointment beforehand to allow enough time to talk. The CEO himself attends the exhibition every year to meet with other top business leaders in the region. 'Arab Health is one of the three trade shows that we attend every year, without fail.  I was there in the early days of Arab Health, and I can testify to the progress it has made.  It is now the world's leading healthcare exhibition and congress. Thanks to its location in Dubai, it is an excellent place to meet highly competent partners from all over the world. In Dubai, people still have time for constructive discussion, which is great!'

BIOLABO's stand is open to the thousands of people who use and trust in its products. Decision-makers, laboratory managers and technicians come along to ask their questions, and are given a warm welcome and personal attention by BIOLABO's engineers. BIOLABO provides serums free of charge for assessing the quality of medical tests as part of a vast program involving numerous hospitals and large NGOs (Médecins Sans Frontières, the UNRWA for Palestine Refugees in the Near East, etc.).

This year, BIOLABO will be exhibiting all of its reagents and analyzers. The spotlight will be on SOLEA 100, and a training session on this particular analyzer will be held during the exhibition, in a private room.

From January 25 to 28, 2016, BIOLABO will be exhibiting its products at the French Pavilion at Arab Health in Dubai (MEDLAB hall - Za’abeel Hall7 - Z7E19 -French pavilion)